Show simple item record

dc.contributor.authorFernandez, Mercedes
dc.contributor.authorBonkovsky, Herbert L.
dc.date2022-08-11T08:09:48.000
dc.date.accessioned2022-08-23T16:44:09Z
dc.date.available2022-08-23T16:44:09Z
dc.date.issued2003-06-06
dc.date.submitted2008-04-14
dc.identifier.citation<p>Br J Pharmacol. 2003 Jun;139(3):634-40. <a href="http://dx.doi.org/10.1038/sj.bjp.0705272 ">Link to article on publisher's site</a></p>
dc.identifier.issn0007-1188 (Print)
dc.identifier.doi10.1038/sj.bjp.0705272
dc.identifier.pmid12788823
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40445
dc.description.abstract(1) Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. It has been recently suggested that the inducible heme oxygenase (HO-1) isoform may play a role in angiogenesis. (2) The aims of this study were to determine, in chicken embryo chorioallantoic membranes (CAM), whether VEGF increases HO-1 protein expression, and, if so, by which molecular mechanism, and whether HO-1 activity is required for VEGF-induced angiogenesis. (3) Treatment of CAMs with VEGF for 48 h caused a significant increase in HO-1 protein expression, simultaneously with angiogenesis. (4) VEGF-stimulated angiogenesis in CAMs was markedly attenuated by the HO inhibitor zinc mesoporphyrin (ZnMP). This inhibitory effect of ZnMP was not observed with copper mesoporphyrin (CuMP), a metalloporphyrin that has a similar structure to ZnMP but does not inhibit HO enzymatic activity. (5) Overexpression of HO-1 protein elicited by VEGF in CAMs was significantly attenuated by the intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA-AM). The effects of BAPTA-AM were, in turn, compensated by the calcium ionophore A-23187. (6) In addition, the protein kinase C inhibitor staurosporine significantly attenuated, in a dose-dependent manner, the VEGF-stimulated HO-1 induction observed in CAMs. (7) These results demonstrate, for the first time, that VEGF upregulates HO-1 protein expression in vivo in CAMs by a mechanism dependent on an increase in cytosolic calcium levels and activation of protein kinase C. Our findings also suggest that HO-1 activity is necessary for VEGF-induced angiogenesis in CAMs.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12788823&dopt=Abstract ">Link to article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573871/
dc.subjectAllantois
dc.subjectAnimals
dc.subjectChick Embryo
dc.subjectChorion
dc.subjectGene Expression Regulation, Enzymologic
dc.subjectHeme Oxygenase (Decyclizing)
dc.subjectHeme Oxygenase-1
dc.subjectHumans
dc.subjectMembrane Proteins
dc.subjectUp-Regulation
dc.subjectVascular Endothelial Growth Factor A
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleVascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane
dc.typeJournal Article
dc.source.journaltitleBritish journal of pharmacology
dc.source.volume139
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/325
dc.identifier.contextkey489663
html.description.abstract<p>(1) Vascular endothelial growth factor (VEGF) is a potent angiogenic factor. It has been recently suggested that the inducible heme oxygenase (HO-1) isoform may play a role in angiogenesis. (2) The aims of this study were to determine, in chicken embryo chorioallantoic membranes (CAM), whether VEGF increases HO-1 protein expression, and, if so, by which molecular mechanism, and whether HO-1 activity is required for VEGF-induced angiogenesis. (3) Treatment of CAMs with VEGF for 48 h caused a significant increase in HO-1 protein expression, simultaneously with angiogenesis. (4) VEGF-stimulated angiogenesis in CAMs was markedly attenuated by the HO inhibitor zinc mesoporphyrin (ZnMP). This inhibitory effect of ZnMP was not observed with copper mesoporphyrin (CuMP), a metalloporphyrin that has a similar structure to ZnMP but does not inhibit HO enzymatic activity. (5) Overexpression of HO-1 protein elicited by VEGF in CAMs was significantly attenuated by the intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA-AM). The effects of BAPTA-AM were, in turn, compensated by the calcium ionophore A-23187. (6) In addition, the protein kinase C inhibitor staurosporine significantly attenuated, in a dose-dependent manner, the VEGF-stimulated HO-1 induction observed in CAMs. (7) These results demonstrate, for the first time, that VEGF upregulates HO-1 protein expression in vivo in CAMs by a mechanism dependent on an increase in cytosolic calcium levels and activation of protein kinase C. Our findings also suggest that HO-1 activity is necessary for VEGF-induced angiogenesis in CAMs.</p>
dc.identifier.submissionpathoapubs/325
dc.contributor.departmentDivision of Gastroenterology
dc.source.pages634-40


This item appears in the following Collection(s)

Show simple item record